Daniel Faissol | Principal Investigator, Center for Bioengineering, Executive Director, Predictive Design of Biologics
Lawrence Livermore National Laboratory

Daniel Faissol, Principal Investigator, Center for Bioengineering, Executive Director, Predictive Design of Biologics, Lawrence Livermore National Laboratory

Dr. Faissol is the program lead for predictive design of biologics at Lawrence Livermore National Laboratory (LLNL) and the PI of the Generative Unconstrained Intelligent Drug Engineering program, which focuses on the computational design of antibodies and antigens. His primary research interest is in developing and integrating methods in machine learning, simulation, optimization and high throughput experiments to accelerate the design of biologics.  He serves on the LLNL Data Science Institute Council and is the lead for the computational and data science area within the LLNL Bioengineering Center. Dr. Faissol joined LLNL after completing a PhD in Industrial and Systems Engineering from the Georgia Institute of Technology in 2008.

Appearances:



Day 1 - Tuesday 29th October @ 16:00

Computationally restoring the potency of an antibody against Omicron

Day 2 - Wednesday 30th October @ 11:45

Computationally optimising monoclonals to pre-empt escape variants for rapid response

last published: 10/Jun/24 12:45 GMT

back to speakers